Medical Dialogues
  • Dermatology
Sign in Signup
This site is intended for healthcare professionals only
Sign in Signup
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
Medical Dialogues
  • Medical News
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Medical Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
  • MDTV
      • Anesthesia
      • CTVS
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • Diet and nutrition
      • ENT
      • Gastroenterology
      • Health Dialogues
      • Health News today
      • Health Shorts
      • Health Updates
      • Health video of the day
      • Laboratory Medicine
      • Latest Videos
      • Latest Webinars
      • MD shorts
      • Medical News Today
      • Medical Updates
      • Medical Video of the day
      • Medicine
      • Medico Legal Update
      • Nephrology
      • Neurology and Neurosurgery
      • Obstetrics and Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics & Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Top Videos
      • Urology
This site is intended for healthcare professionals only
Sign InRegister
Medical Dialogues
Sign inRegister
  • Home
  • Medical news
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Medical Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
  • Case of the Day
  • Editorial
  • Home
  • News
  • Health news
  • Hospital & Diagnostics
  • AIIMS plans extensive...

AIIMS plans extensive campaign to get candidates for Covid-19 vaccine trial

Medical Dialogues BureauBy Medical Dialogues BureauPublished On 2020-12-24T09:00:32+05:30  |  Updated On 24 Dec 2020 3:30 AM GMT
AIIMS plans extensive campaign to get candidates for Covid-19 vaccine trial

There is a mammoth refusal rate for the enrollment of candidates to undergo the Phase III human clinical trials of Covaxin at AIIMS.

New Delhi: The All India Institute of Medical Sciences (AIIMS) has planned for an extensive publicity campaign to achieve the desired number of candidates it committed to the ethics committee for the Phase-III trial of Covid-19 vaccine by Bharat Biotech, currently underway in the institute, the officials informed IANS.The trial underway for Covaxin, the Bharat Biotech vaccine, is struggling...

New Delhi: The All India Institute of Medical Sciences (AIIMS) has planned for an extensive publicity campaign to achieve the desired number of candidates it committed to the ethics committee for the Phase-III trial of Covid-19 vaccine by Bharat Biotech, currently underway in the institute, the officials informed IANS.

The trial underway for Covaxin, the Bharat Biotech vaccine, is struggling to find takers for its shots and this despite the phase-I trial showing "encouraging" results.

Also Read:Irregularities in Salary: AIIMS Delhi Nurses call for indefinite strike, emergency services hit

Sanjay Rai, the doctor who is Principal Investigator for the trial told IANS that the institute will use multiple media to raise awareness and encourage candidates for participation.

"We will advertise in newspapers seeking volunteers for the trial. Posters have already been put up. Our team will also take leads from calls and emails.

"People should come forward to participate in the trial as we will raise awareness about the importance of taking part in the clinical trial to achieve a safe and efficacious vaccine," he said.

There is a mammoth refusal rate for the enrollment of candidates to undergo the Phase-III human clinical trials of Covaxin at AIIMS.

Rai, who also heads the Department of Community Medicine at AIIMS told IANS that in the Phase-III trials, encountered around 80 per cent refusal rate on participation. Refusal rates were round 8 per cent for phase 1 and 2 trials.

"Earlier, when we had to recruit 20 volunteers, around 18 used to give consent for it. Now, for the same number of recruitment, we have to call and interview upto 150 candidates," he said.

In phase I and II, the clinical site had enrolled more than 800 candidates cumulatively while the target for phase III is around 1,500.

Rai stated that the institute is way behind the committed target.

"We had committed around 1,500 participants till December end. However, only 300 recruitments have been done so far. The recruitment of the volunteers is way behind the committed target," Rai said.

He shared that most of the candidates do not wish to turn into volunteers, and are under the impression that vaccines are coming very shortly and they think that they are going to be vaccinated anyway.

Besides, the 50 per cent probability of receiving the vaccine jabs discourages them further, Rai added.

"As it's a double-blind trial, volunteers when informed that they may also be given a placebo as it's a trial phase, refuse for participation.

"The enthusiasm which was seen in the earlier two phases is missing in the third phase.

"Many are under the assumption that a vaccine is anyway coming to India for everyone within a week or 15 days and so they don't want to become part of a trial," he said.

When asked if the adverse events reported in the media have also discouraged the candidates from undergoing the trials, he said that it could be a possibility as well.

However, he accepted that the institute needed to publicise more which it did not do for the third phase. "When the phase I trial was to begin, we needed 100 participants but received over 4,500 applications.

"Even during the phase-II trial, the hospital received around 4,000 applications. Since the response was unexpectedly high, we thought that the turnout for the candidates would be similar and did not advertise to avoid unnecessary crowding," he said.

Also Read:Delhi: AIIMS nursing staff call off strike after HC issues restrainment order

aiims aiims news aiims new delhi all india institute of medical sciences covid 19 covid vaccine 
Source : IANS
Medical Dialogues Bureau
Medical Dialogues Bureau

    Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Decoding the Management of Otitis Media and Role of Amoxicillin

    Decoding the Management of Otitis Media and Role of Amoxicillin

    Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable  connection

    Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable connection

    Treatment challenges in managing Gastroparesis related to PPI Use: Analyzing scope of Probiotics

    Treatment challenges in managing Gastroparesis related to PPI Use: Analyzing scope of Probiotics

    Review: Efficacy of Antiviral Agents Against  Omicron Subvariant BA.2

    Review: Efficacy of Antiviral Agents Against Omicron Subvariant BA.2

    Choice of Antibiotics in Common Infections: Doxycycline or Azithromycin?

    Choice of Antibiotics in Common Infections: Doxycycline or Azithromycin?

    View All

    Journal Club Today

    Uterine Leiomyoma Associated Pain Treated Effectively by Relugolix Combination Therapy

    Uterine Leiomyoma Associated Pain Treated Effectively by Relugolix Combination Therapy

    View All

    Health News Today

    Health Bulletin 27/May/2022

    Health Bulletin 27/May/2022

    View All
    © 2019 All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X